Arya Infraceuticals Private Limited
About Arya Infraceuticals Private Limited
Data last updated:
Arya Infraceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2008PTC179407. Its GSTIN is 27AAGCA9672H1ZA (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ashish Ashok Shah and Shrenik Manharlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 601 6th Floor Arun Chambers Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.95 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹52.44 Lakh (net margin 2.6%) and EBITDA of ₹1.39 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹2.52 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Arya Infraceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address601 6th Floor Arun Chambers Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Arya Infraceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arya Infraceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arya Infraceuticals Private Limited, buy the company report.
Financials of Arya Infraceuticals Private Limited
FY 2025 filings availableArya Infraceuticals Private Limited reported revenue of ₹19.95 Cr (up 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 8% growth in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arya Infraceuticals Private Limited, buy the company report.
Board of directors of Arya Infraceuticals Private Limited
Arya Infraceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Ashok Shah Also directs: Subway Modern Developers Private Limited | Director | 29 Sep 2012 | 14 Years 0 Months | Current |
| Shrenik Manharlal Shah | Director | 09 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Arya Infraceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medi Biotek (India) Private Limited | ₹20.02 Cr (FY 2023) | -56.0% | Chennai, Tamil Nadu, India | |||
| Chacha Medical Agencies Private Limited | ₹20.01 Cr (FY 2017) | 5.0% | Nashik, Maharashtra, India | |||
| Novelty Healthshine Private Limited | ₹20 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Subhra Pharma Priavate Limited | ₹19.98 Cr (FY 2024) | 21.0% | Mumbai, Maharashtra, India | |||
| RR Pharmaceuticals Private Limited | ₹19.98 Cr (FY 2025) | -29.0% | New Delhi, Delhi, India | |||
| Arya Infraceuticals Private Limitedthis company | ₹19.95 Cr (FY 2024) | ₹52.44 Lakh | 2.6% | 8.0% | Mumbai, Maharashtra, India | |
| Indace Chem India Private Limited | ₹19.93 Cr (FY 2024) | -29.0% | Thane, Maharashtra, India | |||
| Raddisun Pharmachem Industries Private Limited | ₹19.93 Cr (FY 2025) | -41.0% | Mumbai, Maharashtra, India | |||
| Raja Tradelinks Private Limited | ₹19.9 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India | |||
| Creation Medicare Private Limited | ₹19.89 Cr (FY 2025) | 68.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Arya Infraceuticals Private Limited, buy the company report.
Auditor
Arya Infraceuticals Private Limited is audited by M M LADIWALA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M M LADIWALA & ASSOCIATES | FY 2020 | 131388W |
Shareholding
The shareholding of Arya Infraceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Arya Infraceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jan 2026 | 101230266 | Others | ₹1.4 Cr | Open | |
| 27 Nov 2021 | 100506420 | Axis Bank Limited | ₹1.12 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Arya Infraceuticals Private Limited has 3 court cases on record: 3 filed by Arya Infraceuticals. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (NMCD) | Filed by the company against Pro Laboratories Private Limited and Anr | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Pro Laboratories Private Limited and Anr | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Pro Laboratories Private Limited and Anr | Pending |
To see the full case history of Arya Infraceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arya Infraceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arya Infraceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCA9672H1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arya Infraceuticals Private Limited, buy the company report.
Recent activity
Arya Infraceuticals Private Limited has 6 board changes on record since 2010: 2 appointments and 4 cessations. The latest: Purvi Shrenik Shah ceased to be Director on 01 Apr 2023.
Frequently asked questions
Arya Infraceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 February 2008 (18+ years old) and is registered under CIN U24233MH2008PTC179407.
Arya Infraceuticals has 2 current directors:
- Ashish Ashok Shah - Director
- Shrenik Manharlal Shah - Director
The latest financial statements of Arya Infraceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arya Infraceuticals is 27AAGCA9672H1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Arya Infraceuticals is U24233MH2008PTC179407. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arya Infraceuticals has 3 court cases on record: 3 filed by the company. 3 are pending.
Arya Infraceuticals was incorporated on 25 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arya Infraceuticals by revenue are Medi Biotek (India) Private Limited, Chacha Medical Agencies Private Limited, Novelty Healthshine Private Limited, Subhra Pharma Priavate Limited, RR Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Purvi Shrenik Shah ceased to be Director on 01 Apr 2023. Shrenik Manharlal Shah was appointed as Director on 09 Apr 2021. Nitin Gordhandas Joshi ceased to be Director on 20 Aug 2019. Arya Infraceuticals has 6 board changes on record in total.
The registered office of Arya Infraceuticals is at 601 6th Floor Arun Chambers Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034.
Arya Infraceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.